Effect of vasoactive drugs on hepatic haemodynamics in bilharzial liver cirrhosis.
D000293:Adolescent; D000328:Adult; D000628:Aminophylline / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D005260:Female; D006801:Humans; D008102:Liver Circulation / Q000187:drug effects*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008109:Liver Diseases, Parasitic / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009756:Nylidrin / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010909:Pituitary Hormones, Posterior / Q000494:pharmacology; D011168:Portal System / Q000187:drug effects*; D011169:Portal Vein / Q000187:drug effects; D012039:Regional Blood Flow; D012552:Schistosomiasis / Q000188:drug therapy*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014690:Venous Pressure / Q000187:drug effects*
D010909:Pituitary Hormones, Posterior; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D000628:Aminophylline; D004295:Dihydroxyphenylalanine; D009756:Nylidrin; D010208:Papaverine